Patents by Inventor YUQING EUGENE CHEN

YUQING EUGENE CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12018297
    Abstract: Provided herein is technology relating to molecular biological manipulation of genes and genomes and particularly, but not exclusively, to CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) methods, compositions, systems, and kits for improved genetic editing.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: June 25, 2024
    Assignee: The Regents of The University of Michigan
    Inventors: Jie Xu, Jifeng Zhang, Yuqing Eugene Chen, Dongshan Yang
  • Publication number: 20240148764
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical agents which function as inhibitors of sodium-glucose cotransporter 1 (SGLT-1) activity. The invention further relates to methods of treating and/or ameliorating symptoms related to cystic fibrosis-related liver disease and diseases characterized with increased SGLT-1 activity, increased endoplasmic reticulum (ER) stress response, and/or increased hepatic inflammation.
    Type: Application
    Filed: March 4, 2022
    Publication date: May 9, 2024
    Inventors: Jie Xu, Kezhong Zhang, Xiubin Liang, Yuqing Eugene Chen
  • Publication number: 20230330259
    Abstract: The present invention relates to nanoparticles complexed with therapeutic agents configured for treating cardiovascular related disorders, and methods of synthesizing the same. In particular, the present invention is directed to compositions comprising synthetic HDL (sHDL) nanoparticles carrying therapeutic agents configured for treating cardiovascular related disorders, methods for synthesizing such sHDL nanoparticles, as well as systems and methods utilizing such sHDL nanoparticles (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutic agents, imaging agents, and/or targeting agents (e.g., in cardiovascular disease diagnosis and/or therapy, etc.))).
    Type: Application
    Filed: May 8, 2023
    Publication date: October 19, 2023
    Inventors: Anna A. Schwendeman, Yuqing Eugene Chen, Yanhong Guo, Jifeng Zhang, Wenmin Yuan, Emily Morin
  • Publication number: 20230321179
    Abstract: The present invention relates to N-acyl amino acid products and their use in diagnosing and treating disease.
    Type: Application
    Filed: August 17, 2021
    Publication date: October 12, 2023
    Inventors: Oren Rom, Jifeng Zhang, Yuqing Eugene Chen, Ying Zhao
  • Publication number: 20230181673
    Abstract: The present disclosure provides a method of treating NAFLD, NASH, and atherosclerosis, comprising administering glycine-containing tripeptide molecule, or a pharmaceutically acceptable salt thereof to a subject.
    Type: Application
    Filed: February 2, 2023
    Publication date: June 15, 2023
    Inventors: Oren Rom, Jifeng Zhang, Ying Zhao, Yuqing Eugene Chen
  • Patent number: 11642419
    Abstract: The present invention relates to nanoparticles complexed with therapeutic agents configured for treating cardiovascular related disorders, and methods of synthesizing the same. In particular, the present invention is directed to compositions comprising synthetic HDL (sHDL) nanoparticles carrying therapeutic agents configured for treating cardiovascular related disorders, methods for synthesizing such sHDL nanoparticles, as well as systems and methods utilizing such sHDL nanoparticles (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutic agents, imaging agents, and/or targeting agents (e.g., in cardiovascular disease diagnosis and/or therapy, etc.))).
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: May 9, 2023
    Assignee: The Regents of the University of Michigan
    Inventors: Anna A. Schwendeman, Yuqing Eugene Chen, Yanhong Guo, Jifeng Zhang, Wenmin Yuan, Emily Morin
  • Publication number: 20220322656
    Abstract: Provided herein are organ preservation solutions and methods of use thereof for preserving organs. In particular, provided herein are preservation solutions comprising a mineralocorticoid receptor antagonist, aldehyde dehydrogenase agonist, and/or histone deacetylase inhibitor, and methods of perfusing and storing an organ while awaiting transplantation or non-transplant surgery.
    Type: Application
    Filed: August 28, 2020
    Publication date: October 13, 2022
    Inventors: Zhong Wang, Paul C. Tang, Yuqing Eugene Chen, Betram Pitt, Francis D. Pagani, Ienglam Lei
  • Publication number: 20210301272
    Abstract: Provided herein is technology relating to molecular biological manipulation of genes and genomes and particularly, but not exclusively, to CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) methods, compositions, systems, and kits for improved genetic editing.
    Type: Application
    Filed: May 6, 2019
    Publication date: September 30, 2021
    Inventors: Jie Xu, Jifeng Zhang, Yuqing Eugene Chen, Dongshan Yang
  • Publication number: 20180250419
    Abstract: The present invention relates to nanoparticles complexed with therapeutic agents configured for treating cardiovascular related disorders, and methods of synthesizing the same. In particular, the present invention is directed to compositions comprising synthetic HDL (sHDL) nanoparticles carrying therapeutic agents configured for treating cardiovascular related disorders, methods for synthesizing such sHDL nanoparticles, as well as systems and methods utilizing such sHDL nanoparticles (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutic agents, imaging agents, and/or targeting agents (e.g., in cardiovascular disease diagnosis and/or therapy, etc.))).
    Type: Application
    Filed: March 25, 2016
    Publication date: September 6, 2018
    Inventors: Anna A. Schwendeman, Yuqing Eugene Chen, Yanhong Guo, Jifeng Zhang, Wenmin Yuan, Emily Morin
  • Publication number: 20180132458
    Abstract: This disclosure relates to transgenic rabbit models of cystic fibrosis, and methods of using these rabbits and their derivatives.
    Type: Application
    Filed: November 16, 2017
    Publication date: May 17, 2018
    Inventors: YUQING EUGENE CHEN, JIFENG ZHANG, JIE XU, FEI SUN